Pfizer Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $14.40B | $12.18B | $2.23B | $755.0M |
| FY2021 | $32.58B | $29.87B | $2.71B | $1.18B |
| FY2022 | $29.27B | $26.03B | $3.24B | $872.0M |
| FY2023 | $8.70B | $4.79B | $3.91B | $525.0M |
| FY2024 | $12.74B | $9.84B | $2.91B | $877.0M |